CD34 and acute myeloid leukemia: Although Regnase-1 mRNA expression was not associated with prognosis, patients whose AML cells exhibited gene expression profiles similar to Regnase-1-deficient CD34− HSCs had a poor prognosis (Fig. 5i, Supplementary Data 1).